Latest News in the pharma Industry
Research & Development
Alvotech and DKSH extend biosimilar partnership in Asia
22 Sep 2020
The companies will commercialize six new biosimilar candidates addressing multiple therapeutic areas.
Read more
Europital launches as a science-driven full-service CRO
22 Sep 2020
Expanded CRO services to support biotechs and mid-sized pharma companies across trials in more than 40 countries.
Read more
Micreos initiates trial to evaluate world's first endolysin-drug as a therapy for atopic dermatitis
22 Sep 2020
The targeted removal of one particular bacterial species from the skin microbiome, while preserving the beneficial ones, represents a new way to treat atopic dermatitis.
Read more
T-knife and Catalent sign tech transfer and manufacturing agreement
21 Sep 2020
Catalent to manufacture clinical batches of T-knife's platform process for TCR-based cell therapy at its site in Gosselies, Belgium, for European trials in 2021.
Read more
Gilead Sciences agrees to buy Immunomedics in $21 billion deal
16 Sep 2020
Acquisition will add Trodelvy, a first-in-class antibody-drug conjugate approved to treat breast cancer.
Read more
Humanigen and Lonza collaborate to expand manufacturing of COVID-19 therapeutic candidate
15 Sep 2020
Humanigen's proprietary monoclonal antibody may prevent and treat cytokine storm, which is believed to trigger the acute respiratory distress syndrome in severe cases of COVID-19.
Read more
Evotec and Bioaster partner to build technology and innovation hub in Lyon
14 Sep 2020
Together, the companies will aim to put forward new research projects against infectious diseases and antimicrobial resistance, potentially creating new therapies and technologies.
Read more
Key trends boosting the post-pandemic CRO market
8 Sep 2020
Hybrid clinical trials leveraging safety-focused, direct-to-consumer logistical solutions are taking center stage, ensuring research continuity.
Read more
INOVIO signs up Thermo Fisher to support COVID-19 vaccine production
8 Sep 2020
The CDMO will support INOVIO's plans to have 100 million doses of COVID-19 vaccine candidate INO-4800 manufactured in 2021.
Read more
Exelixis and Catalent collaborate to develop antibody-drug conjugates
8 Sep 2020
The partnership will focus on developing multiple ADCs using Catalent’s proprietary SMARTag site-specific bioconjugation technology.
Read more
AstraZeneca's COVID-19 vaccine candidate enters Phase III trials in the US
2 Sep 2020
Trial enrolling up to 30,000 adults aged 18 years or over to assess safety, efficacy and immunogenicity of AZD1222 for the prevention of COVID-19.
Read more
New syringe technology could make the 'uninjectable' injectable
25 Aug 2020
Researchers have designed a simple, low-cost device for subcutaneous injection of viscous formulations.
Read more